SON (SON)

$5.3B
Market Cap
9.0
P/E Ratio
0.48
Beta
3.99%
Dividend Yield
Piotroski 6/9Altman Z 1.8 Gray ZoneBeneish M -2.23 CleanROIC−WACC +2.8%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.8.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company exhibits a robust fundamental profile characterized by significant operational leverage and strong profitability metrics. A DuPont decomposition reveals that the 27.6% return on equity is driven primarily by high net margins of 13.3%, supported by moderate asset turnover, indicating efficient capital utilization rather than excessive financial engineering. This quality is corroborated by a Piotroski F-Score of 6/9 and a Beneish M-Score of -2.23, which collectively signal low earnings manipulation risk and solid financial health despite the elevated equity multiplier suggesting leverage plays a secondary role in value creation compared to margin expansion. The return on invested capital stands at 9.1%, providing a baseline for assessing whether current valuation premiums are justified by future spread improvements or if they rely heavily on growth assumptions.

Valuation metrics present a compelling divergence between historical norms and intrinsic valuations, though market sentiment appears cautious. Trading at a forward P/E of 9.0x, the stock is priced significantly below its DCF-derived fair value estimate of $246, implying that current pricing does not fully incorporate the projected revenue growth trajectory or margin sustainability inherent in the business model. This discount suggests the market may be underweighting the quality signals provided by the high ROE and low manipulation scores, potentially leaving upside potential if earnings estimates converge with actual performance rather than conservative expectations embedded in the multiple.

However, insider activity introduces a notable counter-narrative to the otherwise positive fundamental picture. Over the last 90 days, net selling of $90,310 by insiders contrasts sharply with the aggressive revenue growth of 41.7% YoY and the attractive valuation gap relative to fair value. This divergence warrants scrutiny, as insider disposition can sometimes reflect a belief that current stock prices are undervalued or signal concerns about future cash flow conversion despite strong top-line expansion. Investors must weigh whether this selling represents opportunistic profit-taking against stronger fundamentals or serves as a warning regarding potential headwinds not yet visible in the financial statements.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%6.3%8.3%
2%$199$182$109
3%$269$240$132
4%$411$351$166

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=6.3%, terminal growth 3%. Fair value $240 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.8
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.23
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

20.9%
Gross Margin
13.3%
Net Margin
9.1%
ROIC
6.3%
WACC
ROIC − WACC Spread: +2.8%— Positive spread.
+41.7%
Revenue Growth (YoY)
+511.8%
Earnings Growth (YoY)
345.8M
Free Cash Flow
60%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

13.3%
Net Profit Margin
NI ÷ Revenue
×
0.67x
Asset Turnover
Revenue ÷ Assets
×
3.07x
Equity Multiplier
Assets ÷ Equity
=
27.6%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

2.07x
Debt / Equity
1.05x
Current Ratio
4.3x
Interest Coverage
2.2x
Net Debt / EBITDA
3.99%
FCF Yield
1.5B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-90,310
Net Selling
0
Buy Transactions
2
Sale Transactions
2026-02-27HAYNES ERNEST D IIISold 1/6 qtrsSale$89,153
2026-02-25COKER ROBERT HOWARDOther2,060 shares
2026-02-20FULLER RODGER DOther11,198 shares
2026-02-20COKER ROBERT HOWARDOther38,074 shares
2026-02-20HAYNES ERNEST D IIISold 1/6 qtrsOther2,982 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✗ Miss
Est: $1.41
Act: $1.38
-1.9%
Q3
✗ Miss
Est: $1.45
Act: $1.37
-5.6%
Q2
✗ Miss
Est: $1.93
Act: $1.92
-0.3%
Q1
✓ Beat
Est: $1.00
Act: $1.05
+5.5%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

8.1
Forward P/E
PEG Ratio
1.45
Price/Book
988957
Avg Volume
$58.44
52W High
$38.65
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$373M
Tracked Passive Exposure
8
ETFs Holding SON
0.10%
Avg Weight in ETFs
$361B
Total ETF AUM

When investors buy or sell ETFs like DVY or VAW, the fund manager is mechanically forced to buy or sell SON shares regardless of SON's individual fundamentals. We estimate $373M of passive capital is structurally linked to SON through 8 tracked ETFs. Passive flows have a limited but growing influence on SON's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in SON to visualize passive redemption contagion across ETFs and collateral stocks.

SON Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
SONEpicenterVYMETFVXFETFVBRETFLINLow RiskNEMLow RiskCRHLow RiskFCXLow RiskSHWLow Risk
SON Price Drop (%)0

If SON (SON) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Linde plc (LIN) as the most exposed collateral stock, sharing 1 ETFs with SON. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 16 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

SON Ownership Dynamics

Ticker
SON

Float lock-up computed from 17 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

SON Capital Efficiency

How efficiently does SON convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$346M
EBITDA
$1.5B
FCF Conversion
23%
Reinvestment Rate
77%
23% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
9.1%
ROIC − WACC Spread
2.8%

SON converts 23% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 77% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 2.8% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-0778$52.30$4,079.4
2026-05-0475$50.06$3,754.5
2026-04-287,453$50.25$374,513.25
2026-04-2425,698$49.19$1.3M
2026-04-20720$57.41$41,335.2
2026-04-142,791$54.94$153,337.54
2026-03-243$51.78$155.34
2026-03-20331$51.81$17,149.11
2026-03-171,618$53.68$86,854.24
2026-03-04166$55.51$9,214.66
2026-02-2410,440$56.87$593,722.8
2026-02-234$56.45$225.8
2026-02-18227$56.72$12,875.44
2026-02-131,160$51.30$59,508
2026-02-121,118$51.42$57,487.56
2026-02-09178$51.32$9,134.96
2026-02-0650,000$50.82$2.5M
2026-02-02185$48.00$8,880
2026-01-272,183$48.94$106,836.02
2026-01-0527,892$44.37$1.2M
2025-12-29204$43.50$8,874
2025-12-1736,483$43.00$1.6M
2025-11-071,184$40.45$47,892.8
2025-11-061,523$40.85$62,214.55
2025-10-311,609$39.27$63,185.43
2025-10-3016$39.70$635.2
2025-10-2864,495$39.46$2.5M
2025-10-2350$41.49$2,074.5
2025-10-212$40.52$81.04
2025-10-207,335$40.03$293,620.05

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare SON to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.